Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study.
Eur Arch Otorhinolaryngol. 2024 May;281(5):2429-2440. doi: 10.1007/s00405-023-08417-8. Epub 2023 Dec 29.
Eur Arch Otorhinolaryngol. 2024.
PMID: 38157036
Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A "Real-Life" Observational Study in the First Year of Treatment.
De Corso E, Settimi S, Montuori C, Corbò M, Passali GC, Porru DP, Lo Verde S, Spanu C, Penazzi D, Di Bella GA, Nucera E, Bonini M, Paludetti G, Galli J.
De Corso E, et al. Among authors: porru dp.
J Clin Med. 2022 May 10;11(10):2684. doi: 10.3390/jcm11102684.
J Clin Med. 2022.
PMID: 35628815
Free PMC article.
Item in Clipboard
Sinonasal Biomarkers Defining Type 2-High and Type 2-Low Inflammation in Chronic Rhinosinusitis with Nasal Polyps.
De Corso E, Baroni S, Settimi S, Onori ME, Mastrapasqua RF, Troiani E, Moretti G, Lucchetti D, Corbò M, Montuori C, Cantiani A, Porru DP, Lo Verde S, Di Bella GA, Caruso C, Galli J.
De Corso E, et al. Among authors: porru dp.
J Pers Med. 2022 Jul 29;12(8):1251. doi: 10.3390/jpm12081251.
J Pers Med. 2022.
PMID: 36013200
Free PMC article.
Item in Clipboard
Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment.
Torretta S, De Corso E, Nava N, Fraccaroli F, Ferrucci SM, Settimi S, Montuori C, Porru DP, Spanu C, D'Agostino G, Marzano AV, Pignataro L.
Torretta S, et al. Among authors: porru dp.
J Pers Med. 2022 Oct 19;12(10):1734. doi: 10.3390/jpm12101734.
J Pers Med. 2022.
PMID: 36294873
Free PMC article.
Item in Clipboard
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
De Corso E, Pasquini E, Trimarchi M, La Mantia I, Pagella F, Ottaviano G, Garzaro M, Pipolo C, Torretta S, Seccia V, Cantone E, Ciofalo A, Lucidi D, Fadda GL, Pafundi PC, Settimi S, Montuori C, Anastasi F, Pagliuca G, Ghidini A, Cavaliere C, Maffei M, Bussu F, Gallo S, Canevari FRM, Paludetti G, Galli J; Dupireal Italian Study Group.
De Corso E, et al.
Allergy. 2023 Oct;78(10):2669-2683. doi: 10.1111/all.15772. Epub 2023 May 26.
Allergy. 2023.
PMID: 37203259
Item in Clipboard
Comparative real-world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patients.
De Corso E, Porru DP, Corbò M, Montuori C, De Maio G, Mastrapasqua RF, Panfili M, Spanu C, Di Bella GA, D'Agostino G, Rizzuti A, Passali GC, Galli J.
De Corso E, et al. Among authors: porru dp.
Clin Otolaryngol. 2024 May 6. doi: 10.1111/coa.14172. Online ahead of print.
Clin Otolaryngol. 2024.
PMID: 38711363
Item in Clipboard
Cite
Cite